<unk>  <unk>  is a group of metabolic abnormalities resulting from rapid<unk>  of malignant cells and massive release of cell breakdown products into the blood among patients with hematologic malignancies treated with chemotherapy.  Metabolic complications include hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia and hyperuricosuria.
Tumor lysis syndrome
Distributive shock
Sepsis
Multiple organ dysfunction syndrome
Obstructive shock
Neurogenic shock
Proteus syndrome
Cardiorenal syndrome